Medicare Rx Projections: CMS Says Average Per Capita Spending Will Grow 7.5% Per Year
This article was originally published in The Pink Sheet Daily
Overall prescription drug spending growth will be 10% nationally, but Medicare Part D benefit will be able to keep costs to beneficiaries lower, Medicare trustees report says. CMS estimates size of drug benefit at $85 bil. in first year.
You may also be interested in...
The federal government will start dipping into the Medicare trust fund nine years earlier than expected, moving the insolvency date up to 2019, trustees report. The Medicare reform law’s payments to health plans and rural providers contribute to the revised outlook.
Past support for so-called ‘march in’ rights is a red flag for biopharma innovators, but after two days of confirmation hearings, industry can be somewhat reassured.
It remains uncertain whether Acting Commissioner Woodcock will be nominated for the post. Regardless, the drug center she has run for most of three decades is going to have to adjust to new management.